Nov 6
Earnings call
Q3 2020 earnings call
ELAN · Elanco Animal Health Inc · Documents
$26.78
+0.28 (+1.06%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$13.39B
Shares
499.83M
Volume · Nov 13
5.38M
Avg daily vol (3M)
5.33M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2020
Nov 6
Current report
8-K
Financial results
Nov 6
Quarterly report
10-Q
FY2020 Q3, ended Sep 30
Quarterly report for FY2020 Q3
Revenue $889.6M
▲ 15.3%
Net loss $135M
Diluted EPS -$0.29
Oct 15
Current report
8-K/A
Events of Jul 30
Regulation FD disclosure
Sep 30
Current report
8-K
Events of Sep 29
Exit or restructuring costs, Regulation FD disclosure
Aug 3
Jul 30
Earnings call
Q2 2020 earnings call
Jul 30
Current report
8-K
Financial results
Jul 30
Quarterly report
10-Q
FY2020 Q2, ended Jun 30
Quarterly report for FY2020 Q2
Revenue $586.3M
▼ 25.0%
Net loss $53.2M
Diluted EPS -$0.13
Jun 18
Current report
8-K
Events of Jun 15
Entered into a material agreement
May 22
Current report
8-K
Events of May 21
Shareholder vote results
May 7
Earnings call
Q1 2020 earnings call
May 7
Current report
8-K
Financial results
May 7
Quarterly report
10-Q
FY2020 Q1, ended Mar 31
Quarterly report for FY2020 Q1
Revenue $657.7M
▼ 10.0%
Net loss $49.1M
Diluted EPS -$0.12
Apr 20
Current report
8-K
Other events
Apr 8
Proxy statement
DEF 14A
Meeting May 21, 2020
Proxy statement
Apr 8
Proxy statement
DEFA14A
Proxy statement
Mar 25
Current report
8-K
Regulation FD disclosure
Mar 24
Current report
8-K
Regulation FD disclosure
Feb 28
Annual report
10-K
FY2019, ended Dec 31
Annual report for FY2019
Revenue $3.07B
▲ 0.1%
Net income $67.9M
▼ 21.5%
Diluted EPS $0.18
▼ 35.7%
Feb 19
Current report
8-K
Financial results
Feb 4
Current report
8-K
Other events
Jan 27
Current report
8-K
Events of Jan 22
Entered into a material agreement, New debt or off-balance-sheet obligation
Jan 23
Current report
8-K
Events of Jan 22
Regulation FD disclosure
Jan 21
Current report
8-K
Other events
Jan 21
Current report
8-K
Regulation FD disclosure
Jan 21
Registration statement
S-3ASR
Registration statement
Jan 17
Current report
8-K
Entered into a material agreement
Jan 10
Current report
8-K
Financial results
Showing 151–179 of 179 documents
Key facts
CIK
1739104
CUSIP
28414H103
13F (30d)
427 filings
388 filers
Visit website
Investor relations